Home
RVTY
RVTY News

Latest Revvity Inc. (RVTY) News on September 13, 2025

Repligen, Revvity, Avantor, Fortrea, and Azenta Shares Skyrocket, What You Need To Know

StockStory

21 days ago

Repligen, Revvity, Avantor, Fortrea, and Azenta Shares Skyrocket, What You Need To Know

Revvity price target lowered to $110 from $116 at BofA

TipRanks

3 months ago

Revvity price target lowered to $110 from $116 at BofA

Argus Research

3 months ago

RVTY: Raising target price to $101.00

Is Revvity Stock Underperforming the Dow?

Barchart

3 months ago

Is Revvity Stock Underperforming the Dow?

An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 39% Undervalued

Simply Wall St.

3 months ago

An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 39% Undervalued

1 Profitable Stock with Exciting Potential and 2 to Be Wary Of

StockStory

3 months ago

1 Profitable Stock with Exciting Potential and 2 to Be Wary Of

Argus Research

3 months ago

RVTY: Raising target price to $101.00

Pediatrix Medical Group (MD) Down 3.1% Since Last Earnings Report: Can It Rebound?

Zacks

3 months ago

Pediatrix Medical Group (MD) Down 3.1% Since Last Earnings Report: Can It Rebound?

3 Healthcare Stocks Skating on Thin Ice

StockStory

3 months ago

3 Healthcare Stocks Skating on Thin Ice

Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows

Business Wire

3 months ago

Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows

Does The Market Have A Low Tolerance For Revvity, Inc.'s (NYSE:RVTY) Mixed Fundamentals?

Simply Wall St.

3 months ago

Does The Market Have A Low Tolerance For Revvity, Inc.'s (NYSE:RVTY) Mixed Fundamentals?

RVTY Stock Falls Despite the Latest Launch of Automated Instrument

Zacks

4 months ago

RVTY Stock Falls Despite the Latest Launch of Automated Instrument

3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

StockStory

4 months ago

3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

Revvity’s EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing

Business Wire

4 months ago

Revvity’s EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing

3 Mid-Cap Stocks with Questionable Fundamentals

StockStory

4 months ago

3 Mid-Cap Stocks with Questionable Fundamentals

S&P 500 Gains & Losses Today: Supermicro Stock Surges After DataVolt Deal

Investopedia

4 months ago

S&P 500 Gains & Losses Today: Supermicro Stock Surges After DataVolt Deal

Shareholders Will Be Pleased With The Quality of Revvity's (NYSE:RVTY) Earnings

Simply Wall St.

4 months ago

Shareholders Will Be Pleased With The Quality of Revvity's (NYSE:RVTY) Earnings

Argus Research

4 months ago

RVTY: Raising target price to $102.00

Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know

StockStory

4 months ago

Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know

RVTY Q1 Earnings Call: Resilient Performance Amid Academic and Tariff Headwinds, Software and Diagnostics Shine

StockStory

4 months ago

RVTY Q1 Earnings Call: Resilient Performance Amid Academic and Tariff Headwinds, Software and Diagnostics Shine

Argus Research

4 months ago

RVTY: Lowering target price to $95.00

3 S&P 500 Stocks in the Doghouse

StockStory

4 months ago

3 S&P 500 Stocks in the Doghouse

MT Newswires

4 months ago

UBS Upgrades Revvity to Buy from Neutral, Cuts Price Target to $115 From $145

1 Safe-and-Steady Stock with Exciting Potential and 2 to Avoid

StockStory

4 months ago

1 Safe-and-Steady Stock with Exciting Potential and 2 to Avoid

MT Newswires

4 months ago

KeyBanc Adjusts Revvity's Price Target to $135 From $145

Revvity to Present at Upcoming Investor Conferences

Business Wire

4 months ago

Revvity to Present at Upcoming Investor Conferences

Mettler-Toledo (MTD) Q1 Earnings: What To Expect

StockStory

4 months ago

Mettler-Toledo (MTD) Q1 Earnings: What To Expect

Revvity First Quarter 2025 Earnings: EPS Beats Expectations

Simply Wall St.

4 months ago

Revvity First Quarter 2025 Earnings: EPS Beats Expectations

MT Newswires

4 months ago

Baird Adjusts Price Target on Revvity to $125 From $127, Maintains Outperform Rating

MT Newswires

4 months ago

Raymond James Adjusts Price Target on Revvity to $120 From $145, Maintains Outperform Rating

MT Newswires

4 months ago

JPMorgan Adjusts Price Target on Revvity to $100 From $120, Maintains Neutral Rating

MT Newswires

4 months ago

KeyBanc Adjusts Price Target on Revvity to $145 From $135, Maintains Overweight Rating

MT Newswires

4 months ago

TD Cowen Adjusts Price Target on Revvity to $126 From $122, Maintains Buy Rating

MT Newswires

4 months ago

Goldman Sachs Adjusts Price Target on Revvity to $125 From $140, Maintains Buy Rating

Company News for Apr 29, 2025

Zacks

4 months ago

Company News for Apr 29, 2025

MT Newswires

5 months ago

Evercore ISI Adjusts Price Target on Revvity to $116 From $125

Biotech Firm Revvity Reports Better-Than-Expected Earnings

Investopedia

5 months ago

Biotech Firm Revvity Reports Better-Than-Expected Earnings

Revvity (RVTY) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks

5 months ago

Revvity (RVTY) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

MT Newswires

5 months ago

Sector Update: Health Care Stocks Mixed Premarket Monday

MT Newswires

5 months ago

Sector Update: Health Care

Revvity joins peers Thermo Fisher, Danaher in tariff warning, maintains profit outlook

Reuters

5 months ago

Revvity joins peers Thermo Fisher, Danaher in tariff warning, maintains profit outlook

Revvity (RVTY) Beats Q1 Earnings and Revenue Estimates

Zacks

5 months ago

Revvity (RVTY) Beats Q1 Earnings and Revenue Estimates

MT Newswires

5 months ago

Revvity Q1 Adusted Earnings, Revenue Increase; 2025 Revenue Outlook Lifted

Why Revvity (RVTY) Could Beat Earnings Estimates Again

Zacks

5 months ago

Why Revvity (RVTY) Could Beat Earnings Estimates Again

Segmental Performance to Drive RVTY's Q1 Earnings: Is a Beat Likely?

Zacks

5 months ago

Segmental Performance to Drive RVTY's Q1 Earnings: Is a Beat Likely?

Revvity Board Declares Quarterly Dividend

Business Wire

5 months ago

Revvity Board Declares Quarterly Dividend

Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for

Zacks

5 months ago

Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for

3 Cash-Producing Stocks Skating on Thin Ice

StockStory

5 months ago

3 Cash-Producing Stocks Skating on Thin Ice

Argus Research

5 months ago

RVTY: Lowering target price to $97.00

Earnings Preview: Revvity (RVTY) Q1 Earnings Expected to Decline

Zacks

5 months ago

Earnings Preview: Revvity (RVTY) Q1 Earnings Expected to Decline

MT Newswires

5 months ago

Leerink Partners Adjusts Price Target on Revvity to $135 From $140, Keeps Outperform Rating

MT Newswires

5 months ago

Wells Fargo Adjusts Price Target on Revvity to $102 From $130, Keeps Equalweight Rating

MT Newswires

5 months ago

Bernstein Adjusts Price Target on Revvity to $120 From $140, Maintains Market Perform Rating

Argus Research

5 months ago

RVTY: Raising target price to $100.00

What Is Revvity, Inc.'s (NYSE:RVTY) Share Price Doing?

Simply Wall St.

5 months ago

What Is Revvity, Inc.'s (NYSE:RVTY) Share Price Doing?

MT Newswires

5 months ago

BofA Securities Cuts Price Target on Revvity to $116 From $143, Maintains Buy Rating

MT Newswires

5 months ago

KeyBanc Lowers Price Target on Revvity to $135 From $145

Morningstar Research

5 months ago

Analyst Report: Revvity, Inc.

MT Newswires

5 months ago

Barclays Adjusts Price Target on Revvity to $110 From $140

MT Newswires

5 months ago

KeyBanc Adjusts Price Target on Revvity to $145 From $135, Keeps Overweight Rating

Argus Research

5 months ago

RVTY: Lowering target price to $96.00

Revvity to Hold Earnings Call on Monday, April 28, 2025

Business Wire

5 months ago

Revvity to Hold Earnings Call on Monday, April 28, 2025

FDA approves Revvity’s Auto-Pure platform and tuberculosis test combo

Medical Device Network

5 months ago

FDA approves Revvity’s Auto-Pure platform and tuberculosis test combo

MT Newswires

5 months ago

Evercore ISI Adjusts Revvity Price Target to $125 From $138, Maintains Outperform Rating

MT Newswires

5 months ago

Revvity Says FDA Approves Auto-Pure 2400 Liquid Handler for Tuberculosis Test

Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test

Business Wire

5 months ago

Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Zacks

5 months ago

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Argus Research

5 months ago

RVTY: Lowering target price to $110.00

1 Healthcare Stock to Target This Week and 2 to Turn Down

StockStory

5 months ago

1 Healthcare Stock to Target This Week and 2 to Turn Down

Argus Research

6 months ago

RVTY: Lowering target price to $113.00

The total return for Revvity (NYSE:RVTY) investors has risen faster than earnings growth over the last five years

Simply Wall St.

6 months ago

The total return for Revvity (NYSE:RVTY) investors has risen faster than earnings growth over the last five years

Revvity Stock Tumbles Despite Expanding Genomics England Alliance

Zacks

6 months ago

Revvity Stock Tumbles Despite Expanding Genomics England Alliance

Morningstar Research

6 months ago

Analyst Report: Revvity, Inc.

MT Newswires

6 months ago

Revvity Expands Alliance with Genomics England

Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England

Business Wire

6 months ago

Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England

MT Newswires

6 months ago

KeyBanc Adjusts Price Target on Revvity to $145 From $135, Maintains Overweight Rating

Revvity's (NYSE:RVTY) Solid Earnings Have Been Accounted For Conservatively

Simply Wall St.

6 months ago

Revvity's (NYSE:RVTY) Solid Earnings Have Been Accounted For Conservatively

Argus Research

6 months ago

RVTY: Lowering target price to $87.00

MT Newswires

6 months ago

Revvity Says Euroimmun Gets CE Mark for Measles Antibody Detection

Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay

Business Wire

6 months ago

Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay

Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks

StockStory

6 months ago

Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks

Revvity Full Year 2024 Earnings: In Line With Expectations

Simply Wall St.

7 months ago

Revvity Full Year 2024 Earnings: In Line With Expectations

3 Reasons to Sell RVTY and 1 Stock to Buy Instead

StockStory

7 months ago

3 Reasons to Sell RVTY and 1 Stock to Buy Instead

Do Options Traders Know Something About Revvity (RVTY) Stock We Don't?

Zacks

7 months ago

Do Options Traders Know Something About Revvity (RVTY) Stock We Don't?

Argus Research

7 months ago

RVTY: Raising target price to $92.00

MT Newswires

7 months ago

Revvity Wins Permanent Injunction Against Cloud Software Group

Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group

Business Wire

7 months ago

Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group

Revvity to Present at Upcoming Investor Conferences

Business Wire

7 months ago

Revvity to Present at Upcoming Investor Conferences

Argus Research

7 months ago

RVTY: Rating decreased to a SELL

Bretton Fund: “Revvity (RVTY) Has Been On A Roller Coaster Ride The Last Few Years”

Insider Monkey

7 months ago

Bretton Fund: “Revvity (RVTY) Has Been On A Roller Coaster Ride The Last Few Years”

Revvity (NYSE:RVTY) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Simply Wall St.

7 months ago

Revvity (NYSE:RVTY) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Argus Research

7 months ago

RVTY: Lowering target price to $129.00

MT Newswires

7 months ago

Raymond James Adjusts Price Target on Revvity to $145 From $140

MT Newswires

7 months ago

KeyBanc Adjusts Revvity Price Target to $145 From $132

MT Newswires

7 months ago

Bernstein Adjusts Revvity Price Target to $140 From $130, Maintains Market Perform Rating

Revvity Inc (RVTY) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ...

GuruFocus.com

7 months ago

Revvity Inc (RVTY) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ...

Thomson Reuters StreetEvents

7 months ago

Q4 2024 Revvity Inc Earnings Call

Revvity (NYSE:RVTY) Reports Q4 In Line With Expectations

StockStory

7 months ago

Revvity (NYSE:RVTY) Reports Q4 In Line With Expectations

Morningstar Research

7 months ago

Analyst Report: Revvity, Inc.

MT Newswires

7 months ago

Citigroup Raises Price Target on Revvity to $155 From $145

Share on Social Networks: